ClinVar Miner

Submissions for variant NM_000059.3(BRCA2):c.67+16A>G (rs529148674)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000859441 SCV000260976 benign not provided 2018-12-20 criteria provided, single submitter clinical testing
Integrated Genetics/Laboratory Corporation of America RCV000204458 SCV000494409 likely benign Hereditary breast and ovarian cancer syndrome 2016-04-15 criteria provided, single submitter clinical testing Variant summary: The c.67+16A>G variant affects a non-conserved intronic nucleotide. Mutation taster predicts benign outcome for this variant. 5/5 programs in Alamut predict that this variant does not affect normal splicing. This variant is found in 18/105310 control chromosomes at a frequency of 0.0001709, predominantly found in South Asian subpopulation with observed MAF of 0.00125, which exceeds the maximal expected frequency of a pathogenic allele (0.0007503), suggesting this variant is likely a benign polymorphism primarily found in the South Asian population. The variant of interest has not, to our knowledge, been reported in affected individuals via publications; nor evaluated for functional impact by in vivo/vitro studies. One clinical lab via ClinVar classified this variant as "benign", without evidence to independently evaluate. Considering all, the variant was classified as likely benign until additional information becomes available.
GeneDx RCV000438848 SCV000520550 likely benign not specified 2016-12-20 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Color RCV000579688 SCV000683799 likely benign Hereditary cancer-predisposing syndrome 2017-02-28 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.